PG241115P148000
- 0.03
- 0.000.00%
Procter & Gamble Newsroom
Duan Yongping and Buffett have a "soul resonance" in their third-quarter operations, and Li Lu re-enters an oil & gas stock.
For nvidia, Bridgewater, Jinglin, Baillie Gifford, and "Cathie Wood" are all reducing their shareholding, and everyone is quietly united in missing the opportunity of nvidia reaching the top of the market cap.
Catalyst Watch: Nvidia Earnings, Microsoft Ignite, Crypto Confidence, and P&G Event
Express News | Toothpaste Makers P&G, Colgate Palmolive and Church & Dwight Shares up Nearly 1.2%; Trump Picks Rfk Jr to Lead Top US Health Agency
Least Shorted S&P 500 Stocks in October
Evercore Maintains Procter & Gamble(PG.US) With Buy Rating, Maintains Target Price $183
Procter & Gamble (PG) Receives a Buy From Evercore ISI
The Procter & Gamble Company's (NYSE:PG) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
The top institutions have disclosed their Q3 US stock hold positions! They are still heavily invested in technology stocks, but some signs are emerging.
Recently, the 13F reports of institutional investors in the US stock market have been released one after another, becoming an important channel for outsiders to understand the investment trends on Wall Street.
Short Interest for Most Consumer Staple Industries Fell in October
Always Celebrates a New Era of Zero Feel, Zero Leaks Period Protection With Their Biggest Stunt at Westfield London, as 86% of UK Women Admit to Taking Significant Steps to Avoid Period Mishaps Such as Leaks and Pad Discomfort Each Month
Ray Dalio's Strategic Moves in Q3 2024: A Deep Dive Into Procter & Gamble's Significant ...
Dr. Cameka Smith, Female Founder and CEO of The Boss Network, to Serve as a Presenter During The 2024 HBCU Honors, Presented by Procter & Gamble, Taking Place During Smith's Milestone 15th Anniversary Yearlong Celebration
Dow Rallies 281 Points On Gains For Procter & Gamble, Travelers Shares
FDA recommends stopping the use of common decongestants in cold medicines, glaxosmithkline (GSK.US) and other companies may be affected.
The Food and Drug Administration (FDA) announced on Thursday that it has proposed to remove the oral phenylephrine commonly used in cold and cough syrups from the active ingredients of over-the-counter nasal decongestants and deemed it ineffective.
FDA Proposes Removing Oral Decongestant Phenylephrine From OTC Meds
The Procter & Gamble Company (PG): Steady Sales Growth and Market Leadership
Market Chatter: Unilever, Procter & Gamble Supply Chains Face Risks From Potential US Tariffs on Mexico
Express News | The USA FDA proposed to stop using the common decongestants in cold medicines.
P&G to Webcast Presentation From P&G Investor Day, November 21
Shareholders Would Enjoy A Repeat Of Procter & Gamble's (NYSE:PG) Recent Growth In Returns